Rare diseases
Investigational molecules
Locations
Mommsenstrasse 11, Raecknitz/zschertnitz, 01069 Dresden, Germany
Research activity is centered on acute myeloid leukemia across newly diagnosed, relapsed, refractory, and molecularly relapsing disease, with parallel interest in myelodysplastic syndrome and myelodysplastic neoplasia. The portfolio includes treatment strategies for patients eligible for intensive therapy as well as those requiring less intensive approaches.
Key interests include post-transplant management, relapse prevention, and targeted treatment selection in genetically defined AML and MDS.
Technische Universitaet Dresden runs clinical trials in conditions such as Acute myeloid leukaemia, Myelodysplastic syndrome, Allogenic stem cell transplantation, Pancreatic carcinoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermany
AustriaGermanyGermanyGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
